Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

JATT

Jatt II Acquisition Corp

12.73

Aug 21 • 10:56 AM ET -1.05 (-7.60%)

Financial Shell Companies USA Micro NASD

Today, 10:02 AMNo clear catalyst identified for JATT's 37-41% surge on momentum trading

Scroll to Statements

Index	-
Market Cap	99.32M
Enterprise Value	97.68M
Income	-
Sales	-
Book/sh	7.67
Cash/sh	0.21
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Apr 17, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.66
P/C	60.56
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.19
Current Ratio	5.19
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	24.92%
Insider Trans	0.00%
Inst Own	67.15%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	5.27%
SMA50	11.81%
SMA200	13.43%
Trades

Shs Outstand	7.80M
Shs Float	5.86M
Short Float	0.08%
Short Ratio	0.20
Short Interest	0.00M
52W High	14.50 -12.18%
52W Low	9.99 27.46%
Volatility	8.08% 6.35%
ATR (14)	1.60
RSI (14)	55.94
Beta	-
Rel Volume	28.68
Avg Volume	22.78K
Volume	169,532

Perf Week	1.87%
Perf Month	16.71%
Perf Quarter	15.91%
Perf Half Y	-
Perf YTD	27.33%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	13.78
Price	12.73
Change %	-7.60%

Jun-30-26 06:53AM	Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger (Pharmaceutical Technology)
Jun-29-26 07:00AM	Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases (PR Newswire) +12.98%
Apr-20-26 04:30PM	JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering (GlobeNewswire)

JATT II Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 13, 2026, and is headquartered in Westfield, NJ.

FounderDr. Someit Sidhu M.D.

CFO & COOMr. Nicholas Fernandez

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JATT

Jatt II Acquisition Corp

Upgrade your Finviz experience